State Street Corp Kodiak Sciences Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, State Street Corp holds 849,249 shares of KOD stock, worth $2.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
849,249
Previous 831,169 2.18%
Holding current value
$2.97 Million
Previous $8.27 Million 71.15%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$2.81 - $9.57 $50,804 - $173,025
18,080 Added 2.18%
849,249 $2.39 Million
Q4 2024

Feb 14, 2025
BUY
$2.6 - $10.9 $37,791 - $158,431
14,535 Added 1.78%
831,169 $8.27 Million
Q3 2024

Nov 14, 2024
BUY
$2.2 - $3.25 $32,364 - $47,810
14,711 Added 1.83%
816,634 $2.13 Million
Q2 2024

Aug 14, 2024
BUY
$2.29 - $4.48 $124,640 - $243,837
54,428 Added 7.28%
801,923 $1.88 Million
Q1 2024

May 15, 2024
BUY
$3.01 - $7.45 $81,450 - $201,597
27,060 Added 3.76%
747,495 $3.93 Million
Q4 2023

Feb 14, 2024
BUY
$1.4 - $3.24 $89,419 - $206,942
63,871 Added 9.73%
720,435 $2.19 Million
Q3 2023

Nov 14, 2023
BUY
$1.8 - $7.49 $40,635 - $169,086
22,575 Added 3.56%
656,564 $1.18 Million
Q2 2023

Aug 14, 2023
SELL
$4.3 - $9.48 $1.54 Million - $3.38 Million
-356,991 Reduced 36.02%
633,989 $4.37 Million
Q1 2023

May 15, 2023
BUY
$4.81 - $8.88 $121,914 - $225,072
25,346 Added 2.62%
990,980 $6.14 Million
Q4 2022

Feb 14, 2023
SELL
$6.52 - $8.05 $74,406 - $91,866
-11,412 Reduced 1.17%
965,634 $6.91 Million
Q3 2022

Nov 15, 2022
SELL
$7.57 - $12.5 $60,590 - $100,050
-8,004 Reduced 0.81%
977,046 $7.56 Million
Q2 2022

Aug 15, 2022
BUY
$5.04 - $9.48 $63,181 - $118,841
12,536 Added 1.29%
985,050 $7.53 Million
Q1 2022

May 16, 2022
SELL
$7.09 - $89.45 $2.39 Million - $30.2 Million
-337,187 Reduced 25.75%
972,514 $7.51 Million
Q4 2021

Feb 14, 2022
BUY
$80.85 - $128.49 $8.26 Million - $13.1 Million
102,192 Added 8.46%
1,309,701 $111 Million
Q3 2021

Nov 15, 2021
BUY
$81.97 - $106.94 $1.86 Million - $2.43 Million
22,752 Added 1.92%
1,207,509 $116 Million
Q2 2021

Aug 16, 2021
BUY
$77.2 - $126.54 $13.9 Million - $22.8 Million
179,820 Added 17.89%
1,184,757 $110 Million
Q1 2021

May 17, 2021
SELL
$110.45 - $164.47 $13.4 Million - $19.9 Million
-121,066 Reduced 10.75%
1,004,937 $114 Million
Q4 2020

Feb 16, 2021
SELL
$60.78 - $154.03 $6.38 Million - $16.2 Million
-105,022 Reduced 8.53%
1,126,003 $165 Million
Q3 2020

Nov 10, 2020
SELL
$45.05 - $59.27 $402,837 - $529,992
-8,942 Reduced 0.72%
1,231,025 $72.9 Million
Q2 2020

Aug 14, 2020
BUY
$42.74 - $66.25 $20.6 Million - $32 Million
482,856 Added 63.78%
1,239,967 $67.1 Million
Q1 2020

May 11, 2020
BUY
$38.18 - $73.95 $28.9 Million - $56 Million
757,111 New
757,111 $36.1 Million

Others Institutions Holding KOD

# of Institutions
109
Shares Held
41.8M
Call Options Held
10.9K
Put Options Held
700
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $182M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email